Updates in Oncology - 2018 Philadelphia

With Proceedings from International Medical Meetings

Graphic for 2018 Update in Onc
Thursday, June 14, 2018
5:30 PM - 9:15 PM

Hilton Philadelphia City Avenue
4200 City Avenue
Philadelphia, PA 19131

Abramson Cancer Center

Program Overview

This course is designed to efficiently discuss the most recent clinical advances in oncology. This course will address the questions that have emerged from the latest data presented at major international annual meetings.

Target Audience

This activity has been designed for medical, surgical and radiation oncologists,  hematologists/oncologists, hematology/oncology fellows, radiologists, urologists, gastroenterologists, dermatologists, pulmonologists, oncology nurses, and other healthcare professionals involved in the treatment of patients with cancer.

Learning Objectives

  • Upon completion of this course, participants should be able to:
  • Describe recent advances in immunotherapy for cancer treatment
  • Identify the current clinical approach to CAR T Cell Therapy for cancer
  • Explain how to apply new clinical findings to a broad range of tumor types
  • Identify issues related to extent of therapy by genomics, stage and patient condition


In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Designation of Credit:

  • PHYSICIANS: Penn Medicine designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • PHYSICIAN ASSISTANTS: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 2.5 Category 1 credits for completing this activity.


Penn Medicine, Office of Continuing Medical and Interprofessional Education, adheres to the ACCME Standards for Commercial Support. Faculty and planner’s disclosure information will be made available in the conference materials and syllabus. Faculty members are also expected to disclose to participants any discussion of off-label and / or investigational use of pharmaceutical products or devices within their presentations.

Registration for this event is now closed. Walk-ins are welcomed to this conference.